Clinical Trial Directory
Access the raw data underlying our analyses. We track the primary literature surrounding Lactobacillus rhamnosus (LGG) high-dose therapies.
Efficacy in Post-Antibiotic Disruption
Published: October 2021 | N = 1,240
A double-blind study demonstrating a 42% reduction in AAD incidence when a 50B CFU dose was administered alongside broad-spectrum antibiotics.
Read our analysis →Inulin Prebiotic Synergy
Published: May 2022 | N = 310
Analysis of SCFA (short-chain fatty acid) production when LGG is combined with 200mg of chicory root extract.
Read our analysis →